Actamax 35mg FC tablet.

Indication

Treatment and prevention of osteoporosis in postmenopausal women and in men at high risk of fractures.

Dosage (summary)

The recommended dose is 35 mg taken orally once a week.

Onset of Action / Duration

Effects on bone density may be observed after 3 to 6 months of treatment.

Special Populations

• Elderly patients
• Patients with renal impairment
• Patients with a history of gastrointestinal disorders

Pregnancy & Breastfeeding

Risedronate sodium is not recommended during pregnancy and lactation due to potential risks to the fetus or infant.

Key Drug Interactions

• Antacids containing aluminum, calcium, or magnesium may interfere with absorption.
• Nonsteroidal anti-inflammatory drugs (NSAIDs) may increase gastrointestinal irritation.

Contraindications

• Hypersensitivity to risedronate sodium or any of the excipients.
• Patients with hypocalcemia.
• Patients with severe renal impairment.

Common side effects

• Gastrointestinal disturbances (nausea, diarrhea, constipation, abdominal pain)
• Musculoskeletal pain
• Headache
• Dizziness
• Osteonecrosis of the jaw (rare)

Counselling Points

• Take the tablet first thing in the morning with a full glass of water.
• Do not lie down for at least 30 minutes after taking the tablet.
• Ensure adequate intake of calcium and vitamin D.
• Report any unusual thigh, hip, or groin pain to your healthcare provider.